Clinical Trials in Oregon
Oregon has 173 clinical trials currently recruiting participants, ranking #26 among all states. The most-studied condition is Multiple Myeloma with 7 active trials.
173
Total Trials
173
Recruiting
#26
National Rank
20
Conditions
Trials by Phase
71
Not Applicable
5
Phase 2 / Phase 3
19
Phase 1 / Phase 2
1
Early Phase 1
20
Phase 1
32
Phase 2
20
Phase 3
5
Phase 4
Top Conditions in Oregon
Top Sponsors in Oregon
Cities With Most Trials in Oregon
| # | City | Trials |
|---|---|---|
| 1 | Portland | 152 |
| 2 | Eugene | 17 |
| 3 | Bend | 5 |
| 4 | Medford | 2 |
| 5 | Springfield | 2 |
| 6 | Portand | 1 |
| 7 | Tigard | 1 |
| 8 | Lebanon | 1 |
| 9 | Clackamas | 1 |
Important: This information is for research purposes only. Always talk to your doctor about whether a clinical trial is right for you.
Frequently Asked Questions
Oregon currently has 173 clinical trials actively recruiting participants, making it #26 nationally by total trial count.
The most-studied conditions in Oregon are Multiple Myeloma (7 trials), Myasthenia Gravis (5 trials), Duchenne Muscular Dystrophy (4 trials).
Browse the conditions listed on this page to find trials recruiting in Oregon. Each condition page shows trial details, eligibility criteria in plain English, and contact information. Always talk to your doctor about whether a trial is right for you.
Trial counts reflect currently recruiting studies listed on ClinicalTrials.gov with locations in this state.
The this entity category groups every U.S. clinical trials and research registries entity sharing this attribute. The list above is the data; the paragraphs below explain what the grouping means against the broader the NIH ClinicalTrials.gov registry distribution and how to read the relative rankings within the category.
For readers using this category as a starting point, the per-entity detail pages linked from the table above carry the underlying the NIH ClinicalTrials.gov registry data in full. The category-level view is the filter; the per-entity pages are the actual answer.
Source: ClinicalTrials.gov, 2026.